UBX News and Press, Unity Biotechnology Inc. From 03/11/24

2024-03-11 05:50:46 ET More on related stocks: Oracle Q3 Earnings Preview: Cloud Computing Business In Focus Blink Charging: EV Tailwinds Offer A Path To Profitability In 2025 Ulta Beauty: We Are Not Adding To Our Position Before The Earnings Release (Rating Downgrad...

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced new research published in the peer-reviewed journal Nat...

SOUTH SAN FRANCISCO, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the first patients have been dosed in the Phase 2 ASPIR...

2023-12-06 17:40:37 ET More on Unity Biotechnology Wedbush upgrades Unity Biotechnology to outperform, cites cash runway Unity Biotechnology GAAP EPS of -$1.05 misses by $0.16 Seeking Alpha’s Quant Rating on Unity Biotechnology Historical earnings data...

2023-11-16 13:09:59 ET More on Unity Biotechnology Unity Biotechnology GAAP EPS of -$1.05 misses by $0.16 UNITY Biotechnology to exercise warrants for $4.38M in gross proceeds Seeking Alpha’s Quant Rating on Unity Biotechnology Historical earnings data...

2023-11-16 08:32:33 ET WaveDancer  ( WAVD ) +108% Announces Merger Agreement with Firefly Neuroscience. HNR Acquisition  ( HNRA ) +19% Announces Completion of its Business Combination by Acquisition of Pogo Resources, LLC; HNRA begins Managing and Operating...

Unity Biotechnology Inc. (UBX) is expected to report $-0.87 for Q3 2023

2023-11-14 01:01:35 ET More on Unity Biotechnology UNITY Biotechnology to exercise warrants for $4.38M in gross proceeds Seeking Alpha’s Quant Rating on Unity Biotechnology Historical earnings data for Unity Biotechnology Financial information for Unit...

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2023. ȁ...

2023-11-10 13:20:36 ET More on Unity Biotechnology Seeking Alpha’s Quant Rating on Unity Biotechnology Historical earnings data for Unity Biotechnology Financial information for Unity Biotechnology For further details see: UNITY Biotechnology to ex...